Temporal lobe changes following radiation therapy: imaging and proton MR spectroscopic findings

Radiation therapy for nasopharyngeal carcinoma affects the temporal lobes. This paper characterizes proton MR spectroscopic findings of the temporal lobes and correlates them with imaging changes. Single-voxel proton MR spectroscopic examinations were acquired from 13 healthy adult volunteers (25 spectra) and 18 patients (28 spectra). All patients had biopsy-confirmed nasopharyngeal carcinoma and were previously treated with radiation therapy. Six patients (33%) had a single treatment and 12 (67%) patients had two treatments. Point resolved spectroscopy (PRESS) method was used (TR = 3,000 ms, TE = 135 ms) and data processed automatically using the LCModel software package for metabolite quantification. Voxel size and geometry were adapted to the lesion to reduce skull-base lipid contamination. The metabolites were quantitated relative to water signal. For each location, an additional non-water-suppressed reference scan in fully relaxed conditions was performed. The imaging findings were divided into four categories: I, normal; II, edema only; III, contrast-enhancing lesions; and IV, cystic encephalomalacia. The N-acetyl-aspartate levels were reduced in 27 (96%) spectra. Choline was increased in 3 (11%), normal in 4 (14%), and reduced in 21 (75%) spectra. The creatine level was normal in 8 (29%) spectra and reduced in 20 (71%) spectra. Imaging showed 4 (14%) spectra with category-I imaging findings; 5 (18%) spectra with category-II findings; 15 (54%) spectra with category-III findings; and 4 (14%) spectra with category-IV findings. Magnetic resonance spectroscopy showed reduced N-acetyl-aspartate in radiation-induced temporal lobe changes. Creatine levels were relatively more stable. Choline levels may be increased, normal, or reduced. Imaging findings ranged from normal to contrast-enhancing lesions and cystic encephalomalacia.